
Uppsala Reports editor
@UMCGlobalSafety
Photo: iStock
UMC experts discuss how real-time vaccine surveillance works during a pandemic and the role of VigiBase in helping to ensure public safety.
With COVID-19 vaccinations rolling at full speed in many countries, there’s a lot of talk about vaccine safety monitoring. But what exactly does that mean and how should we be interpreting data on side effects? Uppsala Monitoring Centre’s Helena Sköld and Annette Rudolph walk us through the basics of vaccine pharmacovigilance.
Helena Sköld and Annette Rudolph. Photos: UMC
Subscribe by visiting the Drug Safety Matters website or listen in right here:
Despite limited resources and small database, Eritrea’s national centre – with some expert encouragement – built up the courage and skills to do signal detection. And succeeded.
Signal detection / 20 May 2020
After decades of slow but steady growth, VigiBase has recently entered a new phase of accelerating expansion, driven by a range of converging forces.
Signal detection / 16 September 2021
Ever wondered how safety surveillance differs between vaccines and drugs? Find out in the latest episode of the Drug Safety Matters podcast.
Signal detection / 25 August 2022